Delivery Order SPE2DR25D2007-SPE2DR26FM54F

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for Zoladex 3.6 mg implant syringes, with a ceiling value of $2,155.68 and an ultimate completion date of February 27, 2026.</p> <p>Place of performance is Conshohocken, PA. The order was issued on a firm fixed price basis with no set-aside.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for Zoladex 10.8 mg implant syringes with a ceiling value of $6,055.80 under a firm fixed-price arrangement.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 27, 2026. No set-aside was used.</p>

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 21, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a ceiling value of $1,859.50 and a firm fixed price. This competitively awarded, non-set-aside contract is classified as a delivery order and is scheduled for completion by June 12, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Zoladex 10.8 mg implant syringes, valued at $2,018.60. This firm fixed-price delivery order, which carries an ultimate completion date of February 20, 2026, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a ceiling value of $2,789.25. This is a firm fixed-price delivery order with an ultimate completion date of October 1, 2025, and represents a non-set-aside competitive award. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Zoladex 3.6 mg implant syringes, with a ceiling value of $1,985.82 and a firm fixed price structure. This non-set-aside delivery order is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a specific procurement requirement under a broader contract...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Zoladex 10.8 mg implant syringes with a ceiling value of $23,515.44. This firm fixed-price delivery order, set to be completed by January 14, 2026, will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made on a non-set-aside, competitive basis, reflecting AmerisourceBergen's capability to meet federal procurement standards through...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Zoladex 10.8 mg implant syringes under a firm fixed-price contract with a ceiling value of $5,879. This competitively awarded, non-set-aside delivery order is scheduled for completion by December 5, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial...

The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Zoladex 10.8 mg implant syringes under a firm fixed-price contract with a ceiling value of $7,564.32. The contract is scheduled for ultimate completion by August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and...

The Defense Logistics Agency awarded a $6,055.80 delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Zoladex 10.8 mg implant syringes, with final delivery required by January 29, 2026. This contract utilizes a firm fixed-price structure with no set-aside designation, reflecting a competitive award to the prime contractor. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...